Geert Robaeys

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

IDO and interferon-α-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity

Marieke Wichers, Ger H. Koek, Geert Robaeys et al. · Molecular Psychiatry · 2004 · 441 citations

Nursing, Neuroscience, Psychiatry +13

Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement

Martin Schaefer, Lucile Capuron, Astrid Friebe et al. · Journal of Hepatology · 2012 · 229 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Recommendations for the management of hepatitis C virus infection among people who inject drugs

Jason Grebely, Geert Robaeys, Philip Bruggmann et al. · International Journal of Drug Policy · 2015 · 199 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacotherapy +12

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

Alison D. Marshall, Evan B. Cunningham, Stine Nielsen et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 150 citations · Full text

Pharmacy, Infectious Diseases, Pharmaceutical Policy +13